SCHEMBL14367444

SCHEMBL14367444

Cc1nn(C)cc1CN(C)C(=O)c1cc2nc(-c3ccc(Cl)cc3)cc(C(F)(F)F)n2n1

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.71
KDM4E B2RXH2 8/20 0.71
HSD17B10 Q99714 7/20 0.71
CASP1 P29466 5/20 0.71
KMT2A Q03164 3/20 0.71
CASP7 P55210 2/20 0.71
MEN1 O00255 2/20 0.71
PKM P14618 1/20 0.71
SMN1; SMN2 Q16637 4/20 0.56
HPGD P15428 3/20 0.56
NPSR1 Q6W5P4 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
TP53 P04637 1/20 0.52
TSHR P16473 2/20 0.52
THRB P10828 1/20 0.51
TTR P02766 1/20 0.50
MAPT P10636 4/20 0.49
MAPK1 P28482 1/20 0.46
ESR2 Q92731 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14367441 0.91 KDM4E (0.76) ALDH1A1KDM4EHSD17B10CASP1KMT2A
SCHEMBL14367447 0.87 ALDH1A1 (0.73) ALDH1A1KDM4EHSD17B10CASP1KMT2A
SCHEMBL14367451 0.86 ALDH1A1 (0.56) ALDH1A1KDM4EHSD17B10CASP1KMT2A
SCHEMBL14535590 0.83 ALDH1A1 (0.62) ALDH1A1KDM4EHSD17B10CASP1KMT2A
SCHEMBL16614836 0.82 ALDH1A1 (0.60) ALDH1A1KDM4EHSD17B10CASP1KMT2A
SCHEMBL1720125 0.77 KDM4E (0.80) ALDH1A1KDM4EHSD17B10CASP1CASP7
SCHEMBL1718290 0.77 ALDH1A1 (0.76) ALDH1A1KDM4EHSD17B10CASP1KMT2A
SCHEMBL14367443 0.77 ALDH1A1 (0.56) ALDH1A1KDM4EHSD17B10CASP1KMT2A
SCHEMBL14367630 0.76 KDM4E (0.61) ALDH1A1KDM4EHSD17B10CASP1KMT2A
SCHEMBL1718188 0.76 ALDH1A1 (0.78) ALDH1A1KDM4EHSD17B10CASP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070270408-A1 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines NOVO NORDISK A/S (DK) 2007-11-22 US disclosed
US-20070270408-A1 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines NOVO NORDISK A/S (DK) 2007-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270408-A1 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines HSD3B1, HSD11B1, SRD5A1 ALDH1A1 133/4885KDM4E 3872/4885HSD17B10 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.